They are a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.
January 26, 2018
BofA Merrill Lynch, Leerink Partners, Evercore ISI, Wedbush PacGrow
To view the prospectus for resTORbio, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277